Literature DB >> 3767122

Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis.

M J Thomassen, C A Demko, C F Doershuk, R C Stern, J D Klinger.   

Abstract

The incidence and prevalence of Pseudomonas cepacia pulmonary colonization were noted to be increasing in patients with cystic fibrosis (CF). Previous work had indicated a greater prevalence of P. cepacia among siblings (with CF) of patients colonized by P. cepacia as well as an association of initial positive P. cepacia cultures with a hospitalization. Because of uncertainty regarding the source and mode of transmission, limited precautionary measures were instituted in 1983, including physical separation of hospitalized patients colonized with P. cepacia from non-colonized patients, reeducation of staff concerning basic infection control procedures, explanation to families regarding these precautionary efforts, and institution of separate summer camp sessions. Repeated environmental cultures throughout the hospital were negative for P. cepacia. Coincident with the institution of control measures, a sharp decline in incidence occurred (8.2% in 1983 versus 1.7% in 1984). These results are suggestive of patient-to-patient transmission. Because P. cepacia infections have been associated with shorter survival in some patients with CF, we will continue our current segregation measures.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3767122     DOI: 10.1164/arrd.1986.134.4.669

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  32 in total

1.  Specific and rapid detection by fluorescent in situ hybridization of bacteria in clinical samples obtained from cystic fibrosis patients.

Authors:  M Hogardt; K Trebesius; A M Geiger; M Hornef; J Rosenecker; J Heesemann
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Intercontinental spread of a highly transmissible clone of Pseudomonas cepacia proved by multilocus enzyme electrophoresis and ribotyping.

Authors:  W M Johnson
Journal:  Can J Infect Dis       Date:  1994-03

3.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

4.  Segregation is good for patients with cystic fibrosis.

Authors:  Steven Conway
Journal:  J R Soc Med       Date:  2008-07       Impact factor: 5.344

5.  An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients.

Authors:  T Mann; D Ben-David; A Zlotkin; D Shachar; N Keller; A Toren; A Nagler; G Smollan; A Barzilai; G Rahav
Journal:  Infection       Date:  2010-04-01       Impact factor: 3.553

6.  Pseudomonas cepacia in cystic fibrosis.

Authors:  D E Stableforth; D L Smith
Journal:  Thorax       Date:  1994-07       Impact factor: 9.139

7.  Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard?

Authors:  S L Butler; C J Doherty; J E Hughes; J W Nelson; J R Govan
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

8.  Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.

Authors:  D L Kiska; A Kerr; M C Jones; J A Caracciolo; B Eskridge; M Jordan; S Miller; D Hughes; N King; P H Gilligan
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

9.  Field inversion gel electrophoresis on Pseudomonas cepacia strains isolated from cystic fibrosis patients.

Authors:  G Amalfitano; E Tonolli; F Favari; C Perazzoli; G Cazzola; G Mastella; I Piacentini
Journal:  Eur J Epidemiol       Date:  1996-04       Impact factor: 8.082

10.  Pulmonary evolution of cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or Burkholderia cepacia.

Authors:  I Jacques; J Derelle; M Weber; M Vidailhet
Journal:  Eur J Pediatr       Date:  1998-05       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.